LexDanaLexDanabeta
Inventor

THOMAS R. ALESSI

Inventor
US

Overview

2→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61MDevices for introducing media into, or onto, the body20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A61FFilters implantable into blood vessels10%
A61LMethods or apparatus for sterilising materials or objects in general10%
C07KPeptides10%
Y10TTechnical subjects covered by former us classification10%
PatentTitleYear
12,042,557Rapid establishment and/or termination of substantial steady-state drug delivery202411,246,913Suspension formulation comprising an insulinotropic peptide2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to INTARCIA THERAPEUTICS INC (2)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to I2O THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTARCIA THERAPEUTICS INC22022–2024
I2O THERAPEUTICS INC12024
Locations
LocationPatentsSpan
US22022–2024